| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/12/2001 | EP1032379B1 Composition with azelaic acid |
| 12/12/2001 | EP0981340B1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound |
| 12/12/2001 | EP0971708B1 Nimesulide gel systems for topical use |
| 12/12/2001 | EP0966431B1 Salicylic acid-sphingoid base derivatives and uses thereof |
| 12/12/2001 | EP0907358B1 Uniform drug delivery therapy |
| 12/12/2001 | EP0889730B1 Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
| 12/12/2001 | EP0843560B1 Cellulose diacetate compositions for use in embolizing blood vessels |
| 12/12/2001 | EP0838430B1 Fine particles of petaloid porous hydroxyapatite and process for producing the same |
| 12/12/2001 | EP0785802B1 Saponin preparations and use thereof in iscoms |
| 12/12/2001 | EP0782861B1 Drug compounding ingredients comprising n-substituted-o-toluidine derivative and percutaneously absorbable preparation |
| 12/12/2001 | EP0782456B1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 12/12/2001 | EP0779805B1 Sustained release of peptides from pharmaceutical compositions |
| 12/12/2001 | EP0766570B1 Methods for treating respiratory disease |
| 12/12/2001 | EP0751764B1 Retinal-containing composition |
| 12/12/2001 | EP0732923B1 Pharmaceutical compositions containing HIV protease inhibitors |
| 12/12/2001 | EP0710122B1 Stabilized pharmaceutical peptide compositions |
| 12/12/2001 | EP0671903B1 Topical and transdermal delivery system utilizing submicron oil spheres |
| 12/12/2001 | EP0646019B1 Biotin-DOTA conjugates and their use in pretargeting methods |
| 12/12/2001 | CN1326511A Systemic viral/ligand gene delivery system and gene therapy |
| 12/12/2001 | CN1326505A Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 12/12/2001 | CN1326486A Anionic-cationic polyion complexes comprising zwitterionic monomer component |
| 12/12/2001 | CN1326364A Antiviral formulations comprising propylene glycol and isopropyl alkanoic acid ester |
| 12/12/2001 | CN1326363A Suppositories |
| 12/12/2001 | CN1326350A Fluticasone lotion having improved vasoconstrictor activity |
| 12/12/2001 | CN1326345A Compounds for treatment of estrogen-dependent illnesses and methods for making and using same |
| 12/12/2001 | CN1326341A Dry powder for inhalation |
| 12/12/2001 | CN1326340A Pharmaceutical composition for treatment of acute disorders |
| 12/12/2001 | CN1326339A Controlled release bead, method of producing the same and multiple unit formulation comprising it |
| 12/12/2001 | CN1326338A Process for preparing oral calcium compositions |
| 12/12/2001 | CN1326335A Process for the manufacture of liquid filled capsules |
| 12/12/2001 | CN1326318A Antiparasitic formulations |
| 12/12/2001 | CN1075945C High-polymer encapsulated insulin microsome and its preparation method and use |
| 12/11/2001 | US6329508 Has variable region which binds to transferrin receptors on brain capillary endothelial cells; for drug or diagnostic agent delivery across blood-brain barrier |
| 12/11/2001 | US6329501 Methods and compositions for targeting compounds to muscle |
| 12/11/2001 | US6329413 Stable oil-in-water emulsion; anionic or nonionic hydrophilic, water soluble emulsifier; galactoarabinan, polygalactose, or polyarabinose; skin protectant |
| 12/11/2001 | US6329410 Water-base liquid preparation |
| 12/11/2001 | US6329347 Anticarcinogenic agents using mycobacterium dna, delipidated, deproteinized cell walls |
| 12/11/2001 | US6329341 Method of treating septic shock |
| 12/11/2001 | US6328997 Magnesium bicarbonate |
| 12/11/2001 | US6328996 Polypeptide capable of contacted state and relaxed state |
| 12/11/2001 | US6328995 Stable vitamin and/or carotenoid products in powder form and process for their production |
| 12/11/2001 | US6328994 Orally disintegrable tablets |
| 12/11/2001 | US6328993 Oral administration form for an acid liable active proton pump inhibitor |
| 12/11/2001 | US6328988 Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules |
| 12/11/2001 | US6328984 Selective antibacterial composition |
| 12/11/2001 | US6328983 Cosmetics, skin treatments |
| 12/11/2001 | US6328980 Emulsion composition comprising a fluorohydrocarbon compound and a method for preparing |
| 12/11/2001 | US6328979 Sustained release medicinal compositions |
| 12/11/2001 | US6328972 Compositions and methods for inducing cytotoxic T lymphocyte responses by immunization with protein antigens |
| 12/11/2001 | US6328970 Rapamycin position 27 conjugates |
| 12/11/2001 | US6328965 Vaccine adjuvants |
| 12/11/2001 | US6328953 Polymeric derivatives of camptothecins |
| 12/11/2001 | US6328728 Drug delivery from electrotransport device, dissolving or suspension intensifiers, agar beads, buffers |
| 12/11/2001 | US6328708 Device for controlled anaesthesia, analgesia and /or sedation |
| 12/11/2001 | CA2251742C Drug complex |
| 12/11/2001 | CA2218643C Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
| 12/11/2001 | CA2156931C Titanium dioxide dispersions, cosmetic compositions and methods for using the same |
| 12/11/2001 | CA2136429C Combined vaccines comprising hepatitis b surface antigen and other antigens |
| 12/11/2001 | CA2063883C Long-acting biodegradable microparticles and a process for their preparation |
| 12/06/2001 | WO2001092584A1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 12/06/2001 | WO2001092580A2 Lyophilizable and enhanced compacted nucleic acids |
| 12/06/2001 | WO2001092288A2 Cobalamin compounds useful as antibiotic agents and as imaging agents |
| 12/06/2001 | WO2001092283A2 Cobalamin compounds useful as cardiovascular agents and as imaging agents |
| 12/06/2001 | WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | WO2001092157A1 Micronised barium sulphate |
| 12/06/2001 | WO2001091892A1 Method for producing emulsified composition |
| 12/06/2001 | WO2001091848A2 Medicament-loaded transdermal reservoir and method for its formation |
| 12/06/2001 | WO2001091816A1 Delivery systems comprising biocompatible and bioerodable membranes |
| 12/06/2001 | WO2001091814A2 Polyubiquitin based hydrogel and uses thereof |
| 12/06/2001 | WO2001091808A2 Bioconjugates of nanoparticles as radiopharmaceuticals |
| 12/06/2001 | WO2001091805A2 Compounds for targeting endothelial cells |
| 12/06/2001 | WO2001091803A2 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 12/06/2001 | WO2001091798A2 Tumor activated prodrug compounds |
| 12/06/2001 | WO2001091797A2 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 12/06/2001 | WO2001091782A1 Pralmorelin-containing nasal drop preparations |
| 12/06/2001 | WO2001091780A1 Neuroprotective peptides |
| 12/06/2001 | WO2001091762A1 Zinc-supplementary compositions for oral administration |
| 12/06/2001 | WO2001091757A1 Percutaneous absorption type steroid preparation for external use |
| 12/06/2001 | WO2001091750A1 Use of a celecoxib composition for fast pain relief |
| 12/06/2001 | WO2001091743A1 Patch containing 4-biphenylacetic acid |
| 12/06/2001 | WO2001091742A1 Pharmaceutical composition containing at least a polymer associated or conjugated with at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof |
| 12/06/2001 | WO2001091732A2 Medicament for combating respiratory depression |
| 12/06/2001 | WO2001091729A1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 12/06/2001 | WO2001091727A2 Self-emulsifying active substance formulation and use of this formulation |
| 12/06/2001 | WO2001091725A2 Biologically useful polyphosphates |
| 12/06/2001 | WO2001091724A2 Transdermal delivery of lasofoxifene |
| 12/06/2001 | WO2001091723A2 Fluorinated copolymer surfactants and use thereof in aerosol compositions |
| 12/06/2001 | WO2001091722A2 Water-thin emulsions with low emulsifier levels |
| 12/06/2001 | WO2001091720A2 Preparation of injectable suspensions having improved injectability |
| 12/06/2001 | WO2001091718A2 Occlusive transdermal therapeutic system wit a non-occlusive backing layer |
| 12/06/2001 | WO2001091703A2 Low emulsifier multiple emulsions |
| 12/06/2001 | WO2001091682A1 Composition and applicator for topical substance delivery |
| 12/06/2001 | WO2001091557A1 Extracts of kava-kava |
| 12/06/2001 | WO2001060339A3 Method for the preparation of microspheres which contain colloidal systems |
| 12/06/2001 | WO2001051092A3 Enhanced transport of agents using membrane disruptive agents |
| 12/06/2001 | WO2001045741A3 Methods for preparing pharmaceutical formulations |
| 12/06/2001 | WO2001041734A3 Stable galenic preparations comprising a benzimidazol and method for the production thereof |
| 12/06/2001 | WO2001041702A3 Zinc thiosalicylate, dermatological compositions containing same, in particular in the form of a self-adhesive device and method for preparing same |
| 12/06/2001 | WO2001034647A3 Animal collagens and gelatins |
| 12/06/2001 | WO2001034646A3 Recombinant gelatins |